France, Institutional

Changechevron_right
menu
search

Collaboration in practice: Late-stage biotech

Nilesh Kumar, PhD, Head of Biotech Private Investments
2 min view
2026-09-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
private-b-roll_nilesh-k

The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.

Nilesh Kumar, Head of Biotech Private Investments, explores how working with Wellington’s public-market biotech experts helps his team better understand the feasibility of emerging biotech innovations.

Expert

Read next